Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Mar 14, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	545	$955.54	51,472
Mar 14, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	870	$954.66	52,017
Mar 14, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	576	$953.77	52,887
Mar 14, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	444	$952.40	53,463
Mar 14, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	182	$951.92	53,907
Dec 12, 2023	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	7,657	$856.71	48,306
Dec 11, 2023	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	5,105	$844.09	56,632
Dec 11, 2023	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	669	$844.09	55,963
Dec 08, 2023	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	883	$843.79	58,538
Dec 05, 2023	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	184	$821.46	59,421

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media